JP2005224148A5

JP2005224148A5 -

Download PDF

Info

Publication number: JP2005224148A5
Authority: JP; Japan
Prior art keywords: mdr1; mutation; gene; seq; partial
Prior art date: 2004-02-12
Legal status : Granted

Application number

JP2004035007A

Other languages

English (en)

Japanese (ja)

Other versions

JP4456887B2 (ja

JP2005224148A (ja

Filing date

2004-02-12

Publication date

2006-11-09

2004-02-12 Application filed filed Critical

2004-02-12 Priority to JP2004035007A priority Critical patent/JP4456887B2/ja

2004-02-12 Priority claimed from JP2004035007A external-priority patent/JP4456887B2/ja

2005-08-25 Publication of JP2005224148A publication Critical patent/JP2005224148A/ja

2006-11-09 Publication of JP2005224148A5 publication Critical patent/JP2005224148A5/ja

2010-04-28 Application granted granted Critical

2010-04-28 Publication of JP4456887B2 publication Critical patent/JP4456887B2/ja

2024-02-12 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 claims 9
102100030306 TBC1 domain family member 9 Human genes 0.000 claims 9
230000035772 mutation Effects 0.000 claims 7
101150066553 MDR1 gene Proteins 0.000 claims 6
125000003275 alpha amino acid group Chemical group 0.000 claims 5
108091034117 Oligonucleotide Proteins 0.000 claims 3
238000000034 method Methods 0.000 claims 3
108091033319 polynucleotide Proteins 0.000 claims 3
239000002157 polynucleotide Substances 0.000 claims 3
102000040430 polynucleotide Human genes 0.000 claims 3
108090000765 processed proteins & peptides Proteins 0.000 claims 3
229940079593 drug Drugs 0.000 claims 2
239000003814 drug Substances 0.000 claims 2
239000002773 nucleotide Substances 0.000 claims 2
125000003729 nucleotide group Chemical group 0.000 claims 2
229920001184 polypeptide Polymers 0.000 claims 2
102000004196 processed proteins & peptides Human genes 0.000 claims 2
108090000623 proteins and genes Proteins 0.000 claims 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
206010059866 Drug resistance Diseases 0.000 claims 1
206010064571 Gene mutation Diseases 0.000 claims 1
239000002246 antineoplastic agent Substances 0.000 claims 1
229940041181 antineoplastic drug Drugs 0.000 claims 1
230000000295 complement effect Effects 0.000 claims 1
102000054767 gene variant Human genes 0.000 claims 1
230000035945 sensitivity Effects 0.000 claims 1

JP2004035007A 2004-02-12 2004-02-12 細胞の薬剤感受性の判定法 Expired - Lifetime JP4456887B2 (ja)